Physician
Cardiology
Dr. Burton E. Sobel, MD
|
|
Give Review
Burton Sobel is an expert in the field of Cardiology. He attended Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School has a rank of 1 in research and a 12 in primary care He over the years received 1 awards: "Elected Member". Burton E. Sobel, MD is a published doctor. He published 68 publications, including: 'Improved spatial resolution and electrogram wave direction independence with the use of an orthogonal electrode configuration.'
Publications
- Priming with ligands secreted by human stromal progenitor cells promotes grafts of cardiac stem/progenitor cells after myocardial infarction.
- Improved spatial resolution and electrogram wave direction independence with the use of an orthogonal electrode configuration.
- The Efficacy and Tolerability of Azilsartan in Obese Insulin Resistant Mice with Left Ventricular Pressure Overload.
- The Efficacy and Tolerability of Azilsartan in Mice with Left Ventricular Pressure Overload or Acute Myocardial Infarction.
- Attenuation of cardiac vascular rhexis: a promising therapeutic target.
- On thwarting the seeds of scientific fraud.
- Causes, consequences, and amelioration of late adverse ventricular remodeling after myocardial infarction.
- Toward a comprehensive approach to pharmacoinvasive therapy for patients with ST segment elevation acute myocardial infarction.
- Coagulation and Fibrinolytic System Protein Profiles in Women with Normal Pregnancies and Pregnancies Complicated by Hypertension.
- The impact of pharmacologic sympathetic and parasympathetic blockade on atrial electrogram characteristics in patients with atrial fibrillation.
- Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by cAMP in HepG2 liver cells.
- Reperfusion injury: doublethink or misnomer.
- Absence of altered autophagy after myocardial ischemia in diabetic compared with nondiabetic mice.
- Emergence of Complex Behavior: An Interactive Model of Cardiac Excitation Provides a Powerful Tool for Understanding Electrical Propagation.
- Biomarker profiles as descriptors of left ventricular remodeling after acute myocardial infarction.
- The angiotensin receptor blocker, Azilsartan medoxomil (TAK-491), suppresses vascular wall expression of plasminogen activator inhibitor type-I (PAI-I) protein potenti...
- Meta-analysis of studies of patients in the United Arab Emirates with ST-elevation myocardial infarction treated with thrombolytic agents.
- The temporal variability of dominant frequency and complex fractionated atrial electrograms constrains the validity of sequential mapping in human atrial fibrillation.
- Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction.
- Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigatio...
- The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion.
- A profibrotic effect of plasminogen activator inhibitor type-1 (PAI-1) in the heart.
- Progress in pharmacogenomics and its promise for medicine.
- A novel role for tissue-type plasminogen activator: prevention of thromboembolic occlusion.
- Gender-dependent differences in echocardiographic characteristics of murine hearts.
- A statement on ethics from the HEART Group.
- Contributions of young platelets and of previously activated platelets to platelet reactivity in patients with coronary artery disease.
- Optimizing cardiovascular outcomes in diabetes mellitus.
- Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
- Conundrums in the combined use of anticoagulants and antiplatelet drugs.
- Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment.
- IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPdelta.
- The role of modern biology and medicine in drug development in academia and industry.
- Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
- Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
- Insulin resistance increases PAI-1 in the heart.
- wnt3a but not wnt11 supports self-renewal of embryonic stem cells.
- Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide...
- Quantitative analysis of atherosclerotic lesion composition in mice.
- Enhancement by growth factors of cardiac myocyte differentiation from embryonic stem cells: a promising foundation for cardiac regeneration.
- Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.
- Variation in the ability of glycoprotein IIb-IIIa antagonists to exert and maintain their inhibitory effects on the binding of fibrinogen.
- Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.
- Endothelial dysfunction and inflammation after percutaneous coronary intervention.
- Platelet function, coagulopathy, and impaired fibrinolysis in diabetes.
- Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosis.
- Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).
- Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness.
- Comparison of rapidity of coronary recanalization in men with tenecteplase versus alteplase in acute myocardial infarction.
- Keeping medicine and science together.
- Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1.
- Maladaptive arterial remodeling with systemic hypertension associated with increased concentrations in blood of plasminogen activator inhibitor type-1 (PAI-1).
- Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques.
- Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus.
- Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis.
- Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting.
- Fibrinolysis and diabetes.
- Synergistic treatment of ST-segment elevation myocardial infarction with pharmacoinvasive recanalization.
- Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting.
- Coronary disease in type 1 diabetes: causal contiguity and clinical implications.
- Usefulness of platelet reactivity before percutaneous coronary intervention in determining cardiac risk one year later.
- Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects.
- Effects of glycemic control and other determinants on vascular disease in type 2 diabetes.
- Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk.
- Induction of plasminogen activator inhibitor-1 in endothelial cells by basic fibroblast growth factor and its modulation by fibric acid.
- Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions.
- TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging.
Schools
Harvard Medical School
Peter B Brigham Hospital
National Heart Institute
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Elected Member
Education
-
Brigham and Women's Hospital -
National Institutes of Health Clinical Center -
Harvard Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. James K. O'Brien, MD |
|
|
Dr. Samer Y. Siouffi, MD
 This Doctor is OpenDoctor Recommended.
|